Thanks again for the detailed accelerator mapping — one follow‑up question I’m curious about from a delivery perspective:

In regulated BFSI projects, how do teams typically decide where to draw the line between accelerator reuse vs custom extensions (e.g., survivorship rules, review workflows, or domain‑specific features)?

Is there a common “80/20” split you’ve seen work well in production?